 James Morrison
Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lentiviruses, Primate | 3 | 2023 | 12 | 1.460 |
Why?
| | Immunodeficiency Virus, Feline | 2 | 2023 | 34 | 1.150 |
Why?
| | Gammaretrovirus | 1 | 2020 | 2 | 0.650 |
Why?
| | Spumavirus | 1 | 2020 | 3 | 0.650 |
Why?
| | Immunity, Innate | 5 | 2020 | 846 | 0.630 |
Why?
| | Chiroptera | 1 | 2020 | 62 | 0.610 |
Why?
| | HIV-1 | 8 | 2021 | 905 | 0.580 |
Why?
| | Interferons | 3 | 2025 | 186 | 0.510 |
Why?
| | Cats | 3 | 2023 | 228 | 0.440 |
Why?
| | Virion | 2 | 2019 | 111 | 0.420 |
Why?
| | Lentivirus Infections | 1 | 2014 | 9 | 0.410 |
Why?
| | Cat Diseases | 1 | 2014 | 25 | 0.410 |
Why?
| | Viral Envelope Proteins | 1 | 2014 | 98 | 0.380 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 3 | 2025 | 19 | 0.370 |
Why?
| | RNA, Double-Stranded | 2 | 2025 | 56 | 0.370 |
Why?
| | Virus Replication | 6 | 2021 | 527 | 0.360 |
Why?
| | Picornaviridae | 3 | 2020 | 18 | 0.340 |
Why?
| | Antigens, CD | 1 | 2014 | 557 | 0.320 |
Why?
| | RNA, Viral | 3 | 2025 | 693 | 0.310 |
Why?
| | RNA-Binding Proteins | 2 | 2025 | 461 | 0.250 |
Why?
| | Amino Acid Sequence | 3 | 2023 | 2137 | 0.230 |
Why?
| | RNA Editing | 1 | 2025 | 26 | 0.220 |
Why?
| | Haploinsufficiency | 1 | 2025 | 54 | 0.220 |
Why?
| | Adenosine Deaminase | 1 | 2025 | 43 | 0.220 |
Why?
| | Capsid | 2 | 2021 | 93 | 0.200 |
Why?
| | Human Immunodeficiency Virus Proteins | 1 | 2023 | 6 | 0.190 |
Why?
| | Bone Marrow Stromal Antigen 2 | 1 | 2023 | 11 | 0.190 |
Why?
| | HIV Integrase | 3 | 2014 | 74 | 0.190 |
Why?
| | Protein Sorting Signals | 1 | 2023 | 21 | 0.190 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2023 | 27 | 0.190 |
Why?
| | GPI-Linked Proteins | 1 | 2023 | 81 | 0.190 |
Why?
| | Virus Integration | 3 | 2021 | 69 | 0.180 |
Why?
| | Reverse Transcription | 2 | 2021 | 20 | 0.180 |
Why?
| | RNA Interference | 3 | 2020 | 473 | 0.180 |
Why?
| | Saliva | 1 | 2023 | 247 | 0.170 |
Why?
| | HEK293 Cells | 2 | 2020 | 743 | 0.170 |
Why?
| | Aotidae | 1 | 2020 | 10 | 0.160 |
Why?
| | Cyclophilin A | 1 | 2020 | 27 | 0.160 |
Why?
| | Tripartite Motif Proteins | 1 | 2020 | 39 | 0.160 |
Why?
| | Ferrets | 1 | 2020 | 31 | 0.160 |
Why?
| | 3T3 Cells | 1 | 2020 | 156 | 0.160 |
Why?
| | Host-Pathogen Interactions | 4 | 2021 | 369 | 0.160 |
Why?
| | Cell Line | 4 | 2020 | 2823 | 0.160 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 85 | 0.160 |
Why?
| | RNA Virus Infections | 1 | 2019 | 20 | 0.150 |
Why?
| | Animals | 11 | 2025 | 38141 | 0.150 |
Why?
| | Amino Acids | 1 | 2023 | 521 | 0.140 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2020 | 40 | 0.140 |
Why?
| | Exodeoxyribonucleases | 1 | 2018 | 23 | 0.140 |
Why?
| | Nucleotidyltransferases | 1 | 2018 | 29 | 0.140 |
Why?
| | RNA Viruses | 1 | 2019 | 76 | 0.140 |
Why?
| | RNA, Small Interfering | 1 | 2020 | 632 | 0.140 |
Why?
| | Antiviral Agents | 2 | 2022 | 772 | 0.130 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2011 | 426 | 0.130 |
Why?
| | DNA, Viral | 1 | 2018 | 357 | 0.120 |
Why?
| | Mice | 8 | 2025 | 18338 | 0.120 |
Why?
| | Phosphoproteins | 1 | 2018 | 339 | 0.120 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 553 | 0.120 |
Why?
| | Genes, Viral | 1 | 2015 | 89 | 0.120 |
Why?
| | RNA, Messenger | 1 | 2023 | 2820 | 0.110 |
Why?
| | Gene Knockout Techniques | 1 | 2014 | 117 | 0.100 |
Why?
| | Molecular Sequence Data | 3 | 2014 | 2910 | 0.100 |
Why?
| | Sequence Alignment | 1 | 2014 | 371 | 0.100 |
Why?
| | Viral Proteins | 1 | 2015 | 353 | 0.100 |
Why?
| | Anti-HIV Agents | 1 | 2020 | 908 | 0.090 |
Why?
| | Dogs | 1 | 2014 | 438 | 0.090 |
Why?
| | Molecular Chaperones | 1 | 2014 | 182 | 0.090 |
Why?
| | Transcription Factors | 2 | 2011 | 1733 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 590 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 667 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2014 | 1138 | 0.080 |
Why?
| | Mice, Transgenic | 3 | 2020 | 2189 | 0.070 |
Why?
| | Chromatin | 2 | 2009 | 555 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2025 | 3125 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2021 | 120 | 0.070 |
Why?
| | Humans | 15 | 2025 | 145491 | 0.060 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 376 | 0.060 |
Why?
| | HIV Infections | 2 | 2014 | 3189 | 0.060 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 130 | 0.040 |
Why?
| | Nuclear Pore | 1 | 2021 | 18 | 0.040 |
Why?
| | Deuterium Exchange Measurement | 1 | 2020 | 27 | 0.040 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 1 | 2020 | 28 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 1040 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2021 | 220 | 0.040 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2020 | 7 | 0.040 |
Why?
| | Cytoplasm | 1 | 2021 | 257 | 0.040 |
Why?
| | Disease Resistance | 1 | 2020 | 29 | 0.040 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2020 | 35 | 0.040 |
Why?
| | Protein Binding | 2 | 2021 | 2250 | 0.040 |
Why?
| | Retroviridae Infections | 1 | 2020 | 47 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2021 | 567 | 0.040 |
Why?
| | Immune Evasion | 1 | 2020 | 62 | 0.040 |
Why?
| | Vero Cells | 1 | 2019 | 84 | 0.040 |
Why?
| | Interferon-beta | 1 | 2020 | 92 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2022 | 342 | 0.040 |
Why?
| | Cryoelectron Microscopy | 1 | 2020 | 222 | 0.040 |
Why?
| | Embryonic Development | 1 | 2020 | 125 | 0.040 |
Why?
| | Interferon Type I | 1 | 2020 | 147 | 0.040 |
Why?
| | Viremia | 1 | 2020 | 160 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 491 | 0.040 |
Why?
| | HeLa Cells | 1 | 2020 | 633 | 0.040 |
Why?
| | Protein Domains | 1 | 2020 | 314 | 0.040 |
Why?
| | THP-1 Cells | 1 | 2018 | 20 | 0.040 |
Why?
| | Green Fluorescent Proteins | 2 | 2011 | 407 | 0.030 |
Why?
| | Genome, Viral | 1 | 2019 | 218 | 0.030 |
Why?
| | Viral Load | 1 | 2020 | 528 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2021 | 593 | 0.030 |
Why?
| | Binding Sites | 1 | 2021 | 1313 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5989 | 0.030 |
Why?
| | Monocytes | 1 | 2018 | 536 | 0.030 |
Why?
| | In Situ Hybridization | 1 | 2015 | 318 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 907 | 0.030 |
Why?
| | Cyclophilins | 1 | 2014 | 40 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 751 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 975 | 0.020 |
Why?
| | Virus Assembly | 1 | 2014 | 81 | 0.020 |
Why?
| | Immunoblotting | 1 | 2014 | 294 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 839 | 0.020 |
Why?
| | Blotting, Western | 1 | 2015 | 1162 | 0.020 |
Why?
| | Virus Diseases | 1 | 2015 | 218 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2011 | 4127 | 0.020 |
Why?
| | Biomarkers | 1 | 2023 | 4283 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1710 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2014 | 1049 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2011 | 276 | 0.020 |
Why?
| | Antigens, Viral | 1 | 2009 | 182 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2009 | 153 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 850 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 5202 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2180 | 0.010 |
Why?
| | Cell Survival | 1 | 2009 | 1094 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2009 | 693 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2009 | 743 | 0.010 |
Why?
| | Histones | 1 | 2009 | 663 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2009 | 1468 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2009 | 1487 | 0.010 |
Why?
| | Male | 2 | 2020 | 72817 | 0.010 |
Why?
| | Female | 2 | 2020 | 78763 | 0.010 |
Why?
|
|
Morrison's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|